1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
Vidal, Joan Martínez ; Tsiknakis, Nikos ; Staaf, Johan LU
; Bosch, Ana
LU
; Ehinger, Anna
LU
; Nimeus, Emma
LU
; Salgado, Roberto
; Bai, Yalai
; Rimm, David L.
and Hartman, Johan
, et al.
(2024)
In EClinicalMedicine
78.
- Contribution to journal › Article
- 2023
-
Mark
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms
Sigurjonsdottir, Gudbjörg LU ; De Marchi, Tommaso LU ; Ehinger, Anna LU
; Hartman, Johan
; Bosch, Ana
LU
; Staaf, Johan
LU
; Killander, Fredrika
LU
and Niméus, Emma
LU
(2023)
In Breast Cancer Research
25(1).
- Contribution to journal › Article
- 2020
-
Mark
Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up
Lundgren, Christine LU ; Bendahl, Pär Ola LU ; Ekholm, Maria LU ; Fernö, Mårten LU ; Forsare, Carina LU
; Krüger, Ute
LU
; Nordenskjöld, Bo
; Stål, Olle
and Rydén, Lisa
LU
(2020)
In Breast Cancer Research
22(1).
- Contribution to journal › Article
- 2017
-
Mark
Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer
Allaoui, Roni LU ; Hagerling, Catharina LU ; Desmond, Eva ; Warfvinge, Carl Fredrik LU ; Jirström, Karin LU
and Leandersson, Karin
LU
(2017)
In Cancer Biomarkers
20(4).
p.395-409
- Contribution to journal › Article